Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 214226
Company: LUPIN

Products on ANDA 214226

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TENOFOVIR ALAFENAMIDE	TENOFOVIR ALAFENAMIDE FUMARATE	EQ 25MG BASE	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 214226

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/30/2023	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214226Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 214226

TENOFOVIR ALAFENAMIDE

TABLET;ORAL; EQ 25MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
TENOFOVIR ALAFENAMIDE	TENOFOVIR ALAFENAMIDE FUMARATE	EQ 25MG BASE	TABLET;ORAL	Prescription	No	AB	214226	LUPIN
VEMLIDY	TENOFOVIR ALAFENAMIDE FUMARATE	EQ 25MG BASE	TABLET;ORAL	Prescription	Yes	AB	208464	GILEAD SCIENCES INC